Case Law post CJEU ruling Huawei v ZTE
gb jp cn

Back to main 4iP Council site

Canon v Sieg/Kmp Printtechnik/Part Depot, Higher Regional Court (Oberlandesgericht) of Düsseldorf

29 April 2016 - Case No. I-15 U 47/15

http://caselaw.4ipcouncil.com/german-court-decisions/olg-dusseldorf/canon-v-siegkmp-printtechnikpart-depot-olg-dusseldorf

  1. Facts
    The proceedings before the court concerned the subsequent appeal of Defendants in Case LG Düsseldorf, 11 June 2015 – Case No. 4a O 44/14 (decision rendered before Huawei) seeking to set aside the decision of the lower court.
    Claimant, a Japanese company that produces and markets photocopiers, printers and cartridges in cooperation with undertaking “C”, is the proprietor of European patent 2 087 AAA B1 which has not been declared essential to a particular standard. Defendants “1”, “2” and “3” are involved in the supply and distribution, inter alia to Germany, of cartridges of brand “E”, being based on recycled models of and serving as substitutes for particular OEM-cartridges of Claimant. In 2011, Claimant and “C” made a commitment towards the EU Commission that their products would comply with EU-Directive 2009/125/EC. Part of this commitment is the obligation to secure interoperability of the products with non-OEM cartridges.
    The admissible appeal of Defendants has been rejected by the court of second instance.
  2. Court’s reasoning
    Even though the commitment made toward the EU Commission does, contrary to the opinion of Claimant, not constitute merely a non-binding memorandum but rather a binding declaration it executes Article 15 (2) Directive 2009/125/EC and has the sole purpose of enhancing the environmental performance of the products at issue. Hence, it can be considered neither as a direct nor as an indirect FRAND declaration and the Huawei obligations do not apply in the present case. [1] In consequence, Claimant is not obliged to present a licensing offer corresponding to FRAND terms. [2]
    Nor can Claimant’s seeking of a prohibitory injunction be considered as abusive pursuant to § 242 BGB since Claimant’s declaration could not establish a reliance worthy of protection to the effect that Defendant was entitled to make use of Claimant’s patent protected inventions. [3]
    Moreover, the cumulative conditions established by the ECJ (inter alia in IMS Health) for granting a compulsory license on the basis of Article 102 TFEU absent a standard-setting context are not fulfilled. [4]
  • [1] Ibid, para. 72 et seq.
  • [2] Ibid, para. 74
  • [3] Ibid, para. 48, 78 et seq.
  • [4] Ibid, para. 88 et seq.